Back
Biodexa Pharmaceuticals PLC Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
BDRX
Biodexa Pharmaceuticals PLC
Last Price:
4.36
Seasonality Move:
-24.92%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Biodexa Pharmaceuticals PLC Stock Forecast
-
Is Biodexa Pharmaceuticals PLC Stock Undervalued?
The current Biodexa Pharmaceuticals PLC [BDRX] share price is $3.85. The Score for BDRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. - BDRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Biodexa Pharmaceuticals PLC Stock Go Up Next Year?
Data Unavailable
Biodexa Pharmaceuticals PLC Stock Rating
Data Unavailable
Biodexa Pharmaceuticals PLC Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United Kingdom
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biodexapharma.com
52-Week Data
52-Week High:
220.25
52-Week Low:
3.51
Prediction Charts
Market Cap:
2.24M
Price in USD:
3.85
Volume:
33.02K
Beta:
1.73
Technical Analysis
SMA50:
3.88
SMA100:
2.28
SMA200:
1.72
52-Wk Change:
-94.28%
Stock Predictions
-
Is Biodexa Pharmaceuticals PLC stock public?
Yes, Biodexa Pharmaceuticals PLC is a publicly traded company. -
What is the Biodexa Pharmaceuticals PLC stock quote today?
The Biodexa Pharmaceuticals PLC stock price is 3.85 USD today. -
How to buy Biodexa Pharmaceuticals PLC stock online?
You can buy Biodexa Pharmaceuticals PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-1 | 6.12 | 5.91 | 6.31 | 5.54 |
| Nov-4 | 5.89 | 5.68 | 5.89 | 5.68 |
| Nov-5 | 5.73 | 5.63 | 5.90 | 5.62 |
| Nov-6 | 5.63 | 5.78 | 6.06 | 5.62 |
| Nov-7 | 5.55 | 5.47 | 5.91 | 5.15 |
| Nov-8 | 5.39 | 5.38 | 5.50 | 5.26 |
| Nov-11 | 5.38 | 5.15 | 5.58 | 5.14 |
| Nov-12 | 5.20 | 5.02 | 5.45 | 5.00 |
| Nov-13 | 5.05 | 4.85 | 5.08 | 4.70 |
| Nov-14 | 4.93 | 4.86 | 5.00 | 4.85 |
| Nov-15 | 4.71 | 3.62 | 4.80 | 3.51 |
| Nov-18 | 3.70 | 3.65 | 3.80 | 3.60 |
| Nov-19 | 3.68 | 3.59 | 3.75 | 3.50 |
| Nov-20 | 3.67 | 3.85 | 3.85 | 3.51 |
Biodexa Pharmaceuticals PLC Earnings
Data Unavailable
Biodexa Pharmaceuticals PLC Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.05 per share.
* Biodexa Pharmaceuticals PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.